Visalytics
Visalytics
approved EB-2 (NIW)

Associate Professor

Biotechnology · Sudan · 2023-08-01

Processing Time
22 days
Decision Date
2023-08-01
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize biotechnological research techniques paired with molecular, pharmacological, and microbiological methods to discover novel drugs for the treatment of non-communicable diseases such as cancer and Alzheimer’s disease. This work focuses on enhancing drug efficacy and efficiency to develop therapeutics that reverse symptoms and alleviate healthcare and economic burdens.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses non-communicable diseases like cancer and Alzheimer's, which are imperative to U.S. healthcare and economic stability.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a significant record of 91 publications, 808 citations, and has received funding from esteemed institutions like King Abdulaziz City for Science and Technology.

3 Waiver Benefit Met

The petitioner's work in a critical and emerging technology field justifies waiving the labor certification to advance U.S. medical science and drug manufacturing.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmacy and a prolific record of 91 peer-reviewed articles, 1 patent, and 1 book chapter, which garnered 808 citations. Additionally, the petitioner demonstrated leadership through 50 peer reviews and a role as a principal guest editor for Frontiers of Chemistry, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Professor

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
87 days 2025-01-13
The petitioner proposes to continue research integrating advanced computational techniques and artificial intelligence to decode complex biological mechanisms and identify new drug targets. This work focuses on streamlining drug discovery processes and improving treatment efficacy for complex diseases such as Acute Myeloid Leukemia (AML).
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.
View Case

Research Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Canada 57 days 2025-02-26
The petitioner proposes to continue his work in biotechnology by developing therapeutic molecules through structure-based enzyme engineering. His research focuses on creating novel molecules with anticancer properties and finding new avenues to treat antibiotic-resistant bacterial infections.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Sudan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-08-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 22 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Sudan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist